Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study

Published:2018-06-29 Issue: Volume: Page:
ISSN:2587-0831
Container-title:European Journal of Breast Health
language:
Short-container-title:Eur J Breast Health

Author:

Canda Tulay, ,Yavuz Ekrem,Ozdemir Necmettin,Ilvan Sennur,Sak Dizbay Serpil,Guray Durak Merih,Tuzlali Sitki,Zekioglu Osman,Demir Atakan,Onur Handan,Ustundag Kasim,Goktas Burce, , , , , , , , , , ,

Publisher

Galenos Yayinevi

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists;Journal of Personalized Medicine;2024-04-28

2. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis;Breast Cancer Research and Treatment;2024-03-05

3. Assessing the Impact of Melanin Content on the Reliability of the Idylla™ BRAF Mutation Test;Journal of Molecular Pathology;2023-11-29

4. Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer;Histopathology;2023-03

5. UK recommendations for HER2 assessment in breast cancer: an update;Journal of Clinical Pathology;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP